Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 260–260 | Cite as

Ibrutinib

Drug resistance and myelodysplasia : 6 case reports
Case report
  • 9 Downloads

Reference

  1. Jain P, et al. Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. British Journal of Haematology 183: 578-587, No. 4, Nov 2018. Available from: URL: http://doi.org/10.1111/bjh.15567 - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations